The prognostic value of preoperative serum HDL cholesterol in patients with resectable acral melanoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Clinical and Experimental Medicine

• Publication date

  2017-03-30

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in lipidomics for disease research.

  2016cited by this paper
• Hypertension, serum lipids and cancer risk: A review of epidemiological evidence.

  2016cited by this paper
• The Role of Cholesterol in Cancer.

  2016influential reference
• Melanoma, version 4.2014.

  2014cited by this paper
• Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma.

  2014cited by this paper
• DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells

  2013cited by this paper
• The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics

  2013cited by this paper
• The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects*♦

  2013cited by this paper
• Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.

  2012cited by this paper
• Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review

  2012cited by this paper
• Cholesterol metabolism and cancer: the good, the bad and the ugly.

  2012cited by this paper
• Melanoma: differences between Asian and Caucasian patients.

  2012cited by this paper
• Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma

  2012cited by this paper
• [Post-traumatic acral melanoma: an underestimated reality?].

  2012cited by this paper
• Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?

  2012cited by this paper
• Activated platelets contribute to oxidized low‐density lipoproteins and dysfunctional high‐density lipoproteins through a phospholipase A2‐dependent mechanism

  2012cited by this paper
• Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases

  2011cited by this paper
• Biological activities of HDL subpopulations and their relevance to cardiovascular disease.

  2011cited by this paper
• Prognostic significance of RUNX3 expression in human melanoma

  2011cited by this paper
• Quantitative Proteomics Analysis of Inborn Errors of Cholesterol Synthesis

  2010cited by this paper
• Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort.

  2010cited by this paper
• Final version of 2009 AJCC melanoma staging and classification.

  2009cited by this paper
• Melanoma prognostic factors found in the dermatopathology report.

  2009cited by this paper
• Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.

  2009cited by this paper
• Antiatherogenic small, dense HDL—guardian angel of the arterial wall?

  2006cited by this paper
• Plantar flap reconstruction for acral lentiginous melanoma

  2006cited by this paper
• Dyslipidemia and inflammation: an evolutionary conserved mechanism.

  2005cited by this paper
• [Laboratory markers of melanoma progression].

  2003cited by this paper
• Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects

  2000cited by this paper
• High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.

  1995cited by this paper
• Epidemiologic Data Linking Diet to Hyperlipidemia and Arteriosclerosis

  1992cited by this paper

• Systematic Review and Meta-Analysis of the Prognostic Value of Serum High-Density Lipoprotein Cholesterol Levels for Solid Tumors

  2019cites this paper